Cough News and Research

RSS

India needs political leadership, resources to ensure children's right to health

"India is making positive strides in reducing child mortality through new policies and ambitious programs, but preventing the deaths of millions of children remains one of the country's greatest challenges," health expert and blogger John Butler writes in the Wall Street Journals "India Real Time" blog, noting, "Roughly 1.7 million children under five years old die every year in India, says UNICEF, representing more than a fifth of all child deaths worldwide."

2 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Govs brace for impact of scheduled cuts in home states

The nation's governors met in Washington over the weekend, and among their hottest topics: a White House warning regarding the state-by-state impact of sequestration, which is scheduled to kick in March 1.

26 Feb 2013

Scientists identify mechanosensitive cellular signaling pathway in myofibroblasts

Pulmonary fibrosis is a scarring or thickening of the lungs that causes shortness of breath, a dry cough, fatigue, chest discomfort, weight loss, a decrease in the ability of the lungs to transmit oxygen to the blood stream, and, eventually, heart failure.

24 Feb 2013

Major doctor group coalition expands list of tests, treatments that should be done only rarely

The American Board of Internal Medicine, as part of its "Choosing Wisely" campaign, expanded the number of medical societies recommending caution before certain tests and procedures are ordered.

22 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Immunotherapy could be answer to treating novel coronavirus

Investigation into the mechanism of action of the novelcoronavirus HCoV-EMC, which recently emerged in the Middle East, has revealed that although human bronchial epithelia are very susceptible to infection with the virus, interferon I and III were both able to significantly reduce its replication in cell culture.

20 Feb 2013

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for second quarter of the fiscal year 2013.

14 Feb 2013

State roundup: Ore. considers rural doc loan repayment

Oregon would restore $4 million in the next biennium to fund a loan repayment program that assists primary health care providers willing to work in rural areas, under a bill being pushed by Sen. Elizabeth Steiner Hayward, D-Beaverton. The program ran for nearly two decades before it was cut in 2009 in the depths of the recession.

14 Feb 2013

LASAG trial for severe influenza initiated

...

12 Feb 2013

'Urgent need’ for primary care pneumonia diagnosis tools

While family doctors can exclude pneumonia with a high level of accuracy, they can only identify around a third of radiographically confirmed cases, research shows.

11 Feb 2013

Wichita State associate professor writes two books about flu

The flu: It's a popular topic of conversation lately, as most people probably know someone who has gotten sick this winter. But for Wichita State associate professor George Dehner, the flu is a year-round focus. Dehner, who teaches world and environmental history, recently wrote two books about the flu.

11 Feb 2013

‘Urgent need’ for primary care pneumonia diagnosis tools

While family doctors can exclude pneumonia with a high level of accuracy, they can only identify around a third of radiographically confirmed cases, research shows.

5 Feb 2013

COPD underdiagnosed in Chinese lung cancer patients

Chronic obstructive pulmonary disease is underdiagnosed and undertreated among lung cancer patients in China, study results show.

4 Feb 2013

Measles: an interview with Dr. Robert Perry, World Health Organization

Measles is a disease marked by fever, rash, and cold symptoms (red eyes, cough, runny nose) that results in a temporary suppression of the immune system and a drop in vitamin A levels.

4 Feb 2013

State roundup: Texas lawmakers ready health budget

Texas budget writers got a briefing on the state's health care programs Wednesday, and many of the biggest questions focused on how the state can reduce fraud and what to do about ever-increasing health care costs.

1 Feb 2013

Ten common notions concerning colds and flu

The cold and flu season has hit early and hard this year. As the number of people infected continues to increase, so does the number of internet searches for ways to prevent or limit the duration of viral illnesses. But, what is fact and what is fiction?

1 Feb 2013

CDC: Adult vaccination rates 'unacceptably low'

According to the CDC, a "substantial increase" in immunizations for adults is necessary.

31 Jan 2013

Mount Sinai to initiate immunological therapy trial against chronic pulmonary sarcoidosis

Patients are currently being enrolled in the first clinical trial to investigate the efficacy of immunological therapy for chronic pulmonary sarcoidosis. The trial is being conducted by researchers at the Icahn School of Medicine at Mount Sinai.